메뉴 건너뛰기




Volumn 37, Issue 2, 2010, Pages 105-115

111In- or 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors

Author keywords

111In; 99mTc; Angiogenesis; Nuclear localization sequence, NLS; Vascular endothelial growth factor

Indexed keywords

DOUBLE STRANDED DNA; HISTIDINE; HISTONE H2A; LYSINE; METHANOL; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; RECOMBINANT VASCULOTROPIN; RECOMBINANT VASCULOTROPIN IN 111; RECOMBINANT VASCULOTROPIN TC 99M; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; INDIUM; PEPTIDE; RECOMBINANT PROTEIN; TECHNETIUM; VASCULOTROPIN A;

EID: 76949098852     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.10.001     Document Type: Article
Times cited : (18)

References (23)
  • 1
    • 0029004025 scopus 로고
    • Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
    • Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
    • (1995) Am J Pathol , vol.146 , pp. 1029-1039
    • Dvorak, H.F.1    Brown, L.F.2    Detmar, M.3    Dvorak, A.M.4
  • 2
    • 33745120853 scopus 로고    scopus 로고
    • Antiangiogenic peptides and proteins: from experimental tools to clinical drugs
    • Ruegg C., Hasmim M., Lejeune F.J., and Alghisi G.C. Antiangiogenic peptides and proteins: from experimental tools to clinical drugs. Biochim Biophys Acta 1765 (2006) 155-177
    • (2006) Biochim Biophys Acta , vol.1765 , pp. 155-177
    • Ruegg, C.1    Hasmim, M.2    Lejeune, F.J.3    Alghisi, G.C.4
  • 5
    • 0033859533 scopus 로고    scopus 로고
    • Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
    • van Hagen P.M., Breeman W.A.P., Bernard H.F., Schaar M., Mooij C.M., Srinivasan A., et al. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy. Int J Cancer 90 (2000) 186-198
    • (2000) Int J Cancer , vol.90 , pp. 186-198
    • van Hagen, P.M.1    Breeman, W.A.P.2    Bernard, H.F.3    Schaar, M.4    Mooij, C.M.5    Srinivasan, A.6
  • 8
    • 33847149842 scopus 로고    scopus 로고
    • Biomolecules as targeting vehicles for in situ radiotherapy of malignancies
    • Knaeblein J., and Mueller R. (Eds), Wiley-VCH, Weinheim, Germany
    • Reilly R.M. Biomolecules as targeting vehicles for in situ radiotherapy of malignancies. In: Knaeblein J., and Mueller R. (Eds). Modern biopharmaceuticals: design, development and optimization (2005), Wiley-VCH, Weinheim, Germany 497-526
    • (2005) Modern biopharmaceuticals: design, development and optimization , pp. 497-526
    • Reilly, R.M.1
  • 10
    • 34347356188 scopus 로고    scopus 로고
    • The radiopharmaceutical science of monoclonal antibodies and peptides for imaging and targeted in situ radiotherapy of malignancies
    • Gad S.C. (Ed), John Wiley & Sons, Toronto, Canada
    • Reilly R.M. The radiopharmaceutical science of monoclonal antibodies and peptides for imaging and targeted in situ radiotherapy of malignancies. In: Gad S.C. (Ed). Handbook of biopharmaceutical technology (2007), John Wiley & Sons, Toronto, Canada 987-1053
    • (2007) Handbook of biopharmaceutical technology , pp. 987-1053
    • Reilly, R.M.1
  • 12
    • 0032884409 scopus 로고    scopus 로고
    • Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex
    • Waibel R., Alberto R., Willuda J., Finnern R., Schibi R., Stichelberger A., et al. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 17 (1999) 897-901
    • (1999) Nat Biotechnol , vol.17 , pp. 897-901
    • Waibel, R.1    Alberto, R.2    Willuda, J.3    Finnern, R.4    Schibi, R.5    Stichelberger, A.6
  • 13
    • 0034802915 scopus 로고    scopus 로고
    • Signal transduction by VEGF receptor-1 wild type and mutant proteins
    • Ito N., Huang K., and Claesson-Welsh L. Signal transduction by VEGF receptor-1 wild type and mutant proteins. Cell Signal 13 (2001) 849-854
    • (2001) Cell Signal , vol.13 , pp. 849-854
    • Ito, N.1    Huang, K.2    Claesson-Welsh, L.3
  • 16
    • 42449116224 scopus 로고    scopus 로고
    • Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a P-32/P-33 radionuclide cocktail
    • Lechner A., Blaickner M., Gianolini S., Poljanc K., Aiginger H., and Georg D. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a P-32/P-33 radionuclide cocktail. Phys Med Biol 53 (2008) 1961-1974
    • (2008) Phys Med Biol , vol.53 , pp. 1961-1974
    • Lechner, A.1    Blaickner, M.2    Gianolini, S.3    Poljanc, K.4    Aiginger, H.5    Georg, D.6
  • 17
    • 0026439066 scopus 로고
    • Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6
    • Howell R.W. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 19 (1992) 1371-1383
    • (1992) Med Phys , vol.19 , pp. 1371-1383
    • Howell, R.W.1
  • 18
    • 0029920944 scopus 로고    scopus 로고
    • Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis
    • Keyt B.A., Nguyen H.V., Berleau L.T., Duarte C.M., Park J., Chen H., et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 271 (1996) 5638-5646
    • (1996) J Biol Chem , vol.271 , pp. 5638-5646
    • Keyt, B.A.1    Nguyen, H.V.2    Berleau, L.T.3    Duarte, C.M.4    Park, J.5    Chen, H.6
  • 19
    • 34547786032 scopus 로고    scopus 로고
    • 111In-trastuzumab (Herceptin) modified with nuclear localizing sequences (NLS): a novel Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer
    • 111In-trastuzumab (Herceptin) modified with nuclear localizing sequences (NLS): a novel Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer. J Nucl Med 48 (2007) 1357-1368
    • (2007) J Nucl Med , vol.48 , pp. 1357-1368
    • Costantini, D.1    Chan, C.2    Cai, Z.3    Vallis, K.A.4    Reilly, R.M.5
  • 20
    • 39749174303 scopus 로고    scopus 로고
    • Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications
    • Costantini D.L., Hu M., and Reilly R.M. Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications. Cancer Biother Radiopharm 23 (2008) 3-24
    • (2008) Cancer Biother Radiopharm , vol.23 , pp. 3-24
    • Costantini, D.L.1    Hu, M.2    Reilly, R.M.3
  • 21
    • 33645732101 scopus 로고    scopus 로고
    • Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vesicular function
    • Mukherjee S., Tessema M., and Wandinger-Ness A. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vesicular function. Circ Res 98 (2006) 743-756
    • (2006) Circ Res , vol.98 , pp. 743-756
    • Mukherjee, S.1    Tessema, M.2    Wandinger-Ness, A.3
  • 22
    • 13544267632 scopus 로고    scopus 로고
    • New horizons for VEGF. Is there a role for nuclear localization?
    • Lejbkowicz F., Goldberg-Cohen I., and Levy A.P. New horizons for VEGF. Is there a role for nuclear localization?. Acta Histochem 106 (2005) 405-411
    • (2005) Acta Histochem , vol.106 , pp. 405-411
    • Lejbkowicz, F.1    Goldberg-Cohen, I.2    Levy, A.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.